Altered function of the glutamate aspartate transporter GLAST in glioblastoma
Authors:
- Cristina CorbettaCCCristina Corbetta
- Natalia Di IanniNINatalia Di Ianni
- Maria Grazia BruzzoneMBMaria Grazia Bruzzone
- Monica PatanèMPMonica Patanè
- Bianca PolloBPBianca Pollo
- Gabriele CantiniGCGabriele Cantini
- Manuela CominelliMCManuela Cominelli
- Ileana ZuccaIZIleana Zucca
- Federica PisatiFPFederica Pisati
- Pietro Luigi PolianiPPPietro Luigi Poliani
- Gaetano FinocchiaroGFGaetano Finocchiaro
- Serena PellegattaSPSerena Pellegatta
Preprint
Abstract
In glioma patients, high levels of glutamate can cause brain edema and seizures. GLAST, a glutamate-aspartate transporter expressed by astrocytes with a role in glutamate uptake, is highly expressed on the plasma membrane of glioblastoma (GBM) cells, and its expression significantly correlates with shortened patient survival. Here, it was demonstrated that inhibition of GLAST expression limited the progression and invasion of GBM xenografts. Magnetic resonance spectroscopy was used to measure glutamate in GLAST-expressing gliomas showing that these tumors exhibit increased glutamate concentration. Despite their GLAST expression, GBM stem-like cells (GSCs) released rather than took up glutamate due to their lack of Na+/K+-ATPase. Overexpression of Na+/K+-ATPase in these cells restored glutamate uptake and induced apoptosis. The therapeutic relevance of targeting GLAST in gliomas was assessed using the inhibitor UCPH-101. In glioma-bearing mice, a single intratumoral injection of UCPH-101 significantly increased survival by decreasing GLAST expression and inducing apoptosis. Thus, GLAST has a novel role in GBM that appears to have crucial relevance in glutamate trafficking and may thus be a new therapeutic target.Keywords
All Related Versions
- Published version: International Journal of Cancer, 144 (10), 2539.
This publication has 49 references indexed in Scilit:
- Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization DomainJournal of Neuroscience, 2013
- L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammationJournal of Neuroinflammation, 2012
- Protective Role of STAT3 in NMDA and Glutamate-Induced Neuronal Death: Negative Regulatory Effect of SOCS3PLOS ONE, 2012
- Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunityOncoImmunology, 2012
- Oncogene AEG-1 Promotes Glioma-Induced Neurodegeneration by Increasing Glutamate ExcitotoxicityCancer Research, 2011
- Glutamate release by primary brain tumors induces epileptic activityNature Medicine, 2011
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Autocrine Glutamate Signaling Promotes Glioma Cell InvasionCancer Research, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993